BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep ...

Successful integration of wearables into neurologic practice requires further validation to ensure reliable interpretation of ...

Market Outlook and Growth TrajectoryThe global digital stethoscopes market is expected to grow at a compound annual growth rate (CAGR) of approximately 6% during the forecast period, reflecting the ...

The global MedTech market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next five years. This expansion is driven by rising volumes of surgical and ...

Untreated atrial fibrillation carries an approximately 3 to 5% annual risk of ischemic stroke. Long-term oral anticoagulation therapy decreases this risk to 1.7% with warfarin and to 1.5% with ...

Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a ...

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.

Bronson Methodist is the first facility in southwest Michigan to offer the VARIPULSE™ Pulsed Field Ablation Platform for treating atrial fibrillation ...

Good outcomes relative to bariatric surgery after catheter ablation in observational data ...

Background: Patients with a transient ischemic attack (TIA) or minor stroke have an increased risk of subsequent stroke that persists for at least 10 years. We aimed to identify prognostic factors ...

BridgeBio Pharma (NASDAQ:BBIO) highlighted accelerating U.S. uptake for its transthyretin (TTR) stabilizer Attruby and laid ...